EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTC: FCSC) today announced that its Phase 2 study to evaluate the safety and efficacy of azficel-T (LAVIV®) for the treatment of patients with ...
Fibrocell Science Autologous Fibroblast Injections Show Improvement in Facial Acne Scar Appearance Study Reporting Long-Term Improvement with No Lasting Adverse Effects Accepted for Publication in ...
"Would you like to be young again?" I ask. Many people would jump at the chance of getting back years. But when I ask, "Would you want to revisit those acne years when you were the butt of jokes from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback